Nine Masts Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-183,040
Closed -$1.28M 117
2024
Q2
$1.28M Sell
183,040
-691,460
-79% -$5.23M 0.38% 47
2024
Q1
$9.28M Buy
+874,500
New +$7.65M 2.42% 12
2019
Q2
Sell
-3,025
Closed -$75K 157
2019
Q1
$75K Sell
3,025
-39,352
-93% -$940K 0.02% 106
2018
Q4
$783K Buy
42,377
+38,467
+984% +$915K 0.12% 81
2018
Q3
$100K Sell
3,910
-6,037
-61% -$138K 0.03% 228
2018
Q2
$231K Sell
9,947
-25,748
-72% -$532K 0.04% 163
2018
Q1
$568K Buy
35,695
+35,529
+21,403% +$661K 0.09% 93
2017
Q4
$3K Sell
166
-35,088
-100% -$556K ﹤0.01% 236
2017
Q3
$505K Buy
+35,254
New +$533K 0.07% 58

Other funds holding BHC

Nine Masts Capital's BHC Position: Q3 2024 in Review

Nine Masts Capital sold out of Bausch Health (BHC) in Q3 2024, closing a stake of 183,040 shares — an estimated $1.28M sold.

Nine Masts Capital first reported a position in BHC in Q3 2017 and held it in 9 quarters. The position peaked at $9.28M in Q1 2024. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

  • Nine Masts Capital reported no remaining Bausch Health position as of Q3 2024 after selling out during the quarter.
  • Nine Masts Capital sold 183,040 Bausch Health shares in Q3 2024, an estimated $1.28M.
  • Nine Masts Capital first reported a position in Bausch Health in Q3 2017 and held it in 9 quarters.
  • Nine Masts Capital's Bausch Health position peaked at $9.28M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on Nine Masts Capital's 13F filing for Q3 2024, filed 12 Nov 2024.